| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA680560 | B | Inhibitory activity against glycogen phosphorylase, activity expressed as -logKi | 21 | assay format | Scientific Literature | |||
| 2. | ALA680565 | B | Inhibition of rabbit glycogen phosphorylase B enzyme | Oryctolagus cuniculus | 43 | single protein format | Scientific Literature | ||
| 3. | ALA680567 | B | Inhibitory activity against rabbit muscle glycogen phosphorylase | Oryctolagus cuniculus | 46 | tissue-based format | Scientific Literature | ||
| 4. | ALA874032 | B | The compound was evaluated for the inhibition of glycogen phosphorylase | 20 | assay format | Scientific Literature | |||
| 5. | ALA680572 | B | Inhibitory activity against Pig Skeletal Glycogen Phosphorylase b | Sus scrofa | 73 | single protein format | Scientific Literature | ||
| 6. | ALA680574 | B | Inhibitory binding constant against glycogen phosphorylase B | Oryctolagus cuniculus | 47 | single protein format | Scientific Literature | ||
| 7. | ALA1794345 | F | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | Plasmodium falciparum | 170,142 | organism-based format | PubChem BioAssays | ||
| 8. | ALA1794553 | F | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | Homo sapiens | 58,172 | cell-based format | PubChem BioAssays | ||
| 9. | ALA2114810 | F | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | Homo sapiens | 86,035 | assay format | PubChem BioAssays | ||
| 10. | ALA1614103 | F | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 997 ] | Homo sapiens | 11,883 | assay format | PubChem BioAssays | ||
| 11. | ALA1614211 | F | PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1). (Class of assay: confirmatory) | 36,499 | assay format | PubChem BioAssays | |||
| 12. | ALA1614031 | F | PUBCHEM_BIOASSAY: qHTS Assay for Activators of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 1467, 2100, 2112, 1473, 1466 ] | Homo sapiens | 11,883 | assay format | PubChem BioAssays | ||
| 13. | ALA2354221 | F | PubChem BioAssay. qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT. (Class of assay: confirmatory) | 172,532 | assay format | PubChem BioAssays | |||
| 14. | ALA2429105 | B | Inhibition of glycogen phosphorylase b (unknown origin) | Homo sapiens | 55 | assay format | Scientific Literature |
The page will load shortly, Thanks for your patience!